Gili Regev-Yochay

Reduced Neutralization Efficacy against Omicron Variant after Third Boost of BNT162b2 Vaccine among Liver Transplant Recipients.

Davidov Y, Indenbaum V, Mandelboim M, Asraf K, Gonen T, Tsaraf K, Cohen-Ezra O, Likhter M, Nemet I, Kliker L, Mor O, Doolman R, Cohen C, Afek A, Kreiss Y, Regev-Yochay G, Lustig Y, Ben-Ari Z.

Viruses. 2023 Jan 16. 15(1). PMID: 36680292

The Effect of Macrolides on Mortality in Bacteremic Pneumococcal Pneumonia: A Retrospective, Nationwide Cohort Study, Israel, 2009-2017.

Chowers M, Gerassy-Vainberg S, Cohen-Poradosu R, Wiener-Well Y, Bishara J, Maor Y, Zimhony O, Chazan B, Gottesman BS, Dagan R, Regev-Yochay G.

Clin Infect Dis. 2022 12 19. 75(12):2219-2224. PMID: 35443039

Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up.

Canetti M, Barda N, Gilboa M, Indenbaum V, Mandelboim M, Gonen T, Asraf K, Weiss-Ottolenghi Y, Amit S, Doolman R, Mendelson E, Harats D, Freedman LS, Kreiss Y, Lustig Y, Regev-Yochay G.

Nat Commun. 2022 12 13. 13(1):7711. PMID: 36513665

High Immune Response Rate to the Fourth Boost of the BNT162b2 Vaccine against the Omicron Variants of Concern among Liver Transplant Recipients.

Davidov Y, Indenbaum V, Atari N, Kliker L, Tsaraf K, Asraf K, Cohen-Ezra O, Likhter M, Mor O, Doolman R, Weiss-Ottolenghi Y, Hod T, Afek A, Kreiss Y, Lustig Y, Regev-Yochay G, Mandelboim M, Ben-Ari Z.

Viruses. 2022 Dec 12. 14(12). PMID: 36560773

Maternal and Neonatal Immune Responses Following COVID-19 Infection and Vaccinations in Pregnancy.

Toussia-Cohen S, Nir O, Peretz-Machluf R, Bookstein-Peretz S, Segal O, Asraf K, Doolman R, Regev-Yochay G, Yinon Y.

Vaccines (Basel). 2022 Nov 26. 10(12). PMID: 36560429

Real-World Immunogenicity and Reactogenicity of Two Doses of Pfizer-BioNTech COVID-19 Vaccination in Children Aged 5-11 Years.

Joseph G, Klein E, Lustig Y, Weiss-Ottolenghi Y, Asraf K, Indenbaum V, Amit S, Kriger O, Gilboa M, Levy Y, Pessach IM, Kreiss Y, Regev-Yochay G, Stein M.

Vaccines (Basel). 2022 Nov 18. 10(11). PMID: 36423049

The Association Between Pre-Booster Vaccination Antibody Levels and the Risk of SARS-CoV-2 Infection.

Barda N, Canetti M, Gilboa M, Asraf K, Indenboim V, Weiss-Ottolenghi Y, Amit S, Zubli D, Doolman R, Mendelson E, Freedman LS, Kreiss Y, Lustig Y, Regev-Yochay G.

Clin Infect Dis. 2022 Nov 11. PMID: 36366729

Six-Month Follow-up after a Fourth BNT162b2 Vaccine Dose.

Canetti M, Barda N, Gilboa M, Indenbaum V, Asraf K, Gonen T, Weiss-Ottolenghi Y, Amit S, Doolman R, Mendelson E, Freedman LS, Kreiss Y, Lustig Y, Regev-Yochay G.

N Engl J Med. 2022 12 01. 387(22):2092-2094. PMID: 36351266

Omicron BA.2.75 variant is efficiently neutralised following BA.1 and BA.5 breakthrough infection in vaccinated individuals, Israel, June to September 2022.

Atari N, Kliker L, Zuckerman N, Elkader BA, Weiss-Ottolenghi Y, Mendelson E, Kreiss Y, Regev-Yochay G, Mandelboim M.

Euro Surveill. 2022 11. 27(44). PMID: 36330820

Reply to Paul and Leibovici.

Chowers M, Regev-Yochay G.

Clin Infect Dis. 2022 Oct 12. 75(8):1485. PMID: 35818902